Structures by: Copley R. C.

Total: 32

1-Benzyl-N5-cyclopropyl-N3-methyl-2-oxo-1,2-dihydropyridine-3,5-dicarboxamide

C18H19N3O3

Seal, Jonathan T.Atkinson, Stephen J.Aylott, HelenBamborough, PaulChung, Chun-WaCopley, Royston C. B.Gordon, LaurieGrandi, PaolaGray, James R. J.Harrison, Lee A.Hayhow, Thomas G.Lindon, MatthewMessenger, CassieMichon, Anne-MarieMitchell, DarrenPreston, AlexPrinjha, Rab K.Rioja, InmaculadaTaylor, SimonWall, Ian D.Watson, Robert J.Woolven, James M.Demont, Emmanuel H.

Journal of medicinal chemistry (2020)

a=13.4672(4)Å   b=5.79643(15)Å   c=20.7574(6)Å

α=90.00°   β=97.299(3)°   γ=90.00°

3-{3-[((2R)-3-{[2-(2,3-Dihydro-1H-inden-2-yl)-1,1-dimethylethyl]amino}-2- hydroxypropyl)oxy]-4,5-difluorophenyl}propanoic acid, hydrochloride salt

C25H32F2NO4,Cl

Vogt, Frederick G.Williams, Glenn R.Strohmeier, MarkJohnson, Matthew N.Copley, Royston C. B.

The journal of physical chemistry. B (2014) 118, 34 10266-10284

a=13.6490(13)Å   b=7.6848(14)Å   c=23.486(7)Å

α=90.00°   β=96.889(18)°   γ=90.00°

Ethyl 2-amino-5-isobutyl-1H-imidazole-4-carboxylate

C10H17N3O2

Man, LucasCopley, Royston C. B.Handlon, Anthony L.

Organic & biomolecular chemistry (2019) 17, 27 6566-6569

a=9.7186(3)Å   b=11.7583(4)Å   c=20.8375(6)Å

α=90°   β=96.0696(10)°   γ=90°

Ethyl 2-amino-5-neopentyl-1H-imidazole-4-carboxylate

C11H19N3O2

Man, LucasCopley, Royston C. B.Handlon, Anthony L.

Organic & biomolecular chemistry (2019) 17, 27 6566-6569

a=11.6022(7)Å   b=22.9041(13)Å   c=9.5733(5)Å

α=90°   β=90°   γ=90°

1-(Phenylacetyl)-4-[(2S)-1-(phenylacetyl)-2-pyrrolidinyl]-2,3-dihydro-1H-pyrrole

C24H26N2O2

King, Frank D.Aliev, Abil E.Caddick, StephenCopley, Royston C. B.

Organic & Biomolecular Chemistry (2009) 7, 17 3561-3571

a=5.12520(10)Å   b=19.6810(2)Å   c=9.80400(10)Å

α=90.00°   β=96.1731(6)°   γ=90.00°

2,3-Dichloro-N-[1-methyl-4-(methyloxy)-1H-indazol-3-yl]benzenesulfonamide

C15H13Cl2N3O3S

Miah, Afjal H.Copley, Royston C. B.O'Flynn, DanielPercy, Jonathan M.Procopiou, Panayiotis A.

Organic & biomolecular chemistry (2014) 12, 11 1779-1792

a=7.9294(12)Å   b=12.763(2)Å   c=16.761(3)Å

α=96.664(17)°   β=99.981(17)°   γ=97.378(14)°

2,3-Dichloro-N-[6-chloro-3-({[2-(hydroxymethyl)phenyl]methyl}oxy)-2- pyrazinyl]benzenesulfonamide

C18H14Cl3N3O4S

Miah, Afjal H.Copley, Royston C. B.O'Flynn, DanielPercy, Jonathan M.Procopiou, Panayiotis A.

Organic & biomolecular chemistry (2014) 12, 11 1779-1792

a=9.0361(16)Å   b=20.725(2)Å   c=21.381(6)Å

α=90.00°   β=96.612(16)°   γ=90.00°

2,3-Dichloro-N-[2-(1H-pyrazol-1-yl)phenyl]benzenesulfonamide

C15H11Cl2N3O2S

Miah, Afjal H.Copley, Royston C. B.O'Flynn, DanielPercy, Jonathan M.Procopiou, Panayiotis A.

Organic & biomolecular chemistry (2014) 12, 11 1779-1792

a=7.5758(9)Å   b=8.7573(9)Å   c=23.065(2)Å

α=90.00°   β=91.905(8)°   γ=90.00°

2,3-Dichloro-N-[2-(1H-tetrazol-1-yl)phenyl]benzenesulfonamide

C13H9Cl2N5O2S

Miah, Afjal H.Copley, Royston C. B.O'Flynn, DanielPercy, Jonathan M.Procopiou, Panayiotis A.

Organic & biomolecular chemistry (2014) 12, 11 1779-1792

a=7.4390(9)Å   b=8.4770(12)Å   c=13.0579(15)Å

α=88.763(11)°   β=84.177(10)°   γ=64.880(13)°

(Antipyrine)(4-Aminobenzoic acid)

C11H12N2O,C7H7NO2

Issa, NizarBarnett, Sarah A.Mohamed, SharmarkeBraun, Doris E.Copley, Royston C. B.Tocher, Derek A.Price, Sarah L.

CrystEngComm (2012) 14, 7 2454

a=9.5767(12)Å   b=12.7646(17)Å   c=13.9388(18)Å

α=90.00°   β=90.758(2)°   γ=90.00°

(2,2'-Bipyridine)(Succinic acid)

C10H8N2,C4H6O4

Issa, NizarBarnett, Sarah A.Mohamed, SharmarkeBraun, Doris E.Copley, Royston C. B.Tocher, Derek A.Price, Sarah L.

CrystEngComm (2012) 14, 7 2454

a=8.958(3)Å   b=5.1788(14)Å   c=14.357(4)Å

α=90.00°   β=106.109(4)°   γ=90.00°

2(Phenazine)(4-Aminobenzoic acid)

2(C12H8N2),C7H7NO2

Issa, NizarBarnett, Sarah A.Mohamed, SharmarkeBraun, Doris E.Copley, Royston C. B.Tocher, Derek A.Price, Sarah L.

CrystEngComm (2012) 14, 7 2454

a=15.557(2)Å   b=17.056(3)Å   c=19.782(3)Å

α=80.658(5)°   β=78.559(7)°   γ=77.168(6)°

2(Diphenylcyclopropenone)(Succinic Acid)

C15H10O,0.5(C4H6O4)

Issa, NizarBarnett, Sarah A.Mohamed, SharmarkeBraun, Doris E.Copley, Royston C. B.Tocher, Derek A.Price, Sarah L.

CrystEngComm (2012) 14, 7 2454

a=14.654(4)Å   b=5.5540(14)Å   c=16.288(4)Å

α=90.00°   β=90.471(4)°   γ=90.00°

3-Oxauracil

C4H3NO3

Copley, Royston C. B.Deprez, Lucie S.Lewis, Thomas C.Price, Sarah L.

CrystEngComm (2005) 7, 69 421

a=7.7407(2)Å   b=5.54050(10)Å   c=10.4926(2)Å

α=90.00°   β=103.6430(10)°   γ=90.00°

3-Oxauracil monohydrate

C4H3NO3,H2O

Copley, Royston C. B.Deprez, Lucie S.Lewis, Thomas C.Price, Sarah L.

CrystEngComm (2005) 7, 69 421

a=14.4737(3)Å   b=6.00300(10)Å   c=6.36260(10)Å

α=90.00°   β=90.00°   γ=90.00°

5-hydroxy-2,4(1H,3H)pyrimidinedione

C4H4N2O3

Copley, Royston C. B.Deprez, Lucie S.Lewis, Thomas C.Price, Sarah L.

CrystEngComm (2005) 7, 69 421

a=4.61950(10)Å   b=7.04930(10)Å   c=7.3452(2)Å

α=88.1690(10)°   β=81.5040(10)°   γ=86.2450(10)°

C8H16B10O,0.5H2O

C8H16B10O,0.5H2O

Boyd, Lynn A.Clegg, WilliamCopley, Royston C. B.Davidson, Matthew G.Fox, Mark A.Hibbert, Thomas G.Howard, Judith A. K.Mackinnon, AngusPeace, Richard J.Wade, Kenneth

Dalton transactions (Cambridge, England : 2003) (2004) 17 2786-2799

a=12.628(3)Å   b=6.8043(16)Å   c=16.020(4)Å

α=90.00°   β=96.97(3)°   γ=90.00°

C19H18P,C8H15B10O

C19H18P,C8H15B10O

Boyd, Lynn A.Clegg, WilliamCopley, Royston C. B.Davidson, Matthew G.Fox, Mark A.Hibbert, Thomas G.Howard, Judith A. K.Mackinnon, AngusPeace, Richard J.Wade, Kenneth

Dalton transactions (Cambridge, England : 2003) (2004) 17 2786-2799

a=10.845(1)Å   b=11.260(1)Å   c=11.511(1)Å

α=84.97(1)°   β=86.27(1)°   γ=86.21(1)°

C14H35B10N4OP

C14H35B10N4OP

Boyd, Lynn A.Clegg, WilliamCopley, Royston C. B.Davidson, Matthew G.Fox, Mark A.Hibbert, Thomas G.Howard, Judith A. K.Mackinnon, AngusPeace, Richard J.Wade, Kenneth

Dalton transactions (Cambridge, England : 2003) (2004) 17 2786-2799

a=10.526(3)Å   b=21.680(3)Å   c=12.111(2)Å

α=90.00°   β=115.48(2)°   γ=90.00°

C8H17B10N

C8H17B10N

Boyd, Lynn A.Clegg, WilliamCopley, Royston C. B.Davidson, Matthew G.Fox, Mark A.Hibbert, Thomas G.Howard, Judith A. K.Mackinnon, AngusPeace, Richard J.Wade, Kenneth

Dalton transactions (Cambridge, England : 2003) (2004) 17 2786-2799

a=10.6738(7)Å   b=22.3100(16)Å   c=23.3165(16)Å

α=90.00°   β=102.677(2)°   γ=90.00°

C16H30B20S3

C16H30B20S3

Boyd, Lynn A.Clegg, WilliamCopley, Royston C. B.Davidson, Matthew G.Fox, Mark A.Hibbert, Thomas G.Howard, Judith A. K.Mackinnon, AngusPeace, Richard J.Wade, Kenneth

Dalton transactions (Cambridge, England : 2003) (2004) 17 2786-2799

a=8.0923(3)Å   b=14.8660(7)Å   c=24.1238(8)Å

α=90.00°   β=90.00°   γ=90.00°

(3Z)-5-Cyclopropyl-3-[(4-fluorophenyl)(methylamino)methylidene]- 6-nitro-1-benzofuran-2(3H)-one

C19H15FN2O4

Bowman, Roy K.Bullock, Kae M.Copley, Royston C. B.Deschamps, Nicole M.McClure, Michael S.Powers, Jeremiah D.Wolters, Andy M.Wu, LianmingXie, Shiping

The Journal of organic chemistry (2015) 80, 19 9610-9619

a=7.9217(15)Å   b=20.462(6)Å   c=9.881(2)Å

α=90.00°   β=100.377(18)°   γ=90.00°

0.5:1:6 succinic acid:I:methanol

2(C28H45N2O6),(C4H4O4)2,6(CH4O)

Clawson, Jacalyn S.Vogt, Frederick G.Brum, JeffreySisko, JosephPatience, Daniel B.Dai, WenningSharpe, SonjaJones, Alan D.Pham, Tran N.Johnson, Matthew N.Copley, Royston C. P.

Crystal Growth & Design (2008) 8, 11 4120

a=9.3920(6)Å   b=16.8501(11)Å   c=23.7478(16)Å

α=90.00°   β=90.237(4)°   γ=90.00°

I (disordered succinic acid and solvent)

C28H45N2O6,C4H5O4

Clawson, Jacalyn S.Vogt, Frederick G.Brum, JeffreySisko, JosephPatience, Daniel B.Dai, WenningSharpe, SonjaJones, Alan D.Pham, Tran N.Johnson, Matthew N.Copley, Royston C. P.

Crystal Growth & Design (2008) 8, 11 4120

a=9.5171(11)Å   b=16.7926(19)Å   c=24.166(3)Å

α=90.00°   β=90.00°   γ=90.00°

6-[(5-Chloro-2-{[(4-chloro-2-fluorophenyl)methyl]oxy}phenyl)methyl]- 2-pyridinecarboxylic acid

C20H14Cl2FNO3

Ismail, Salima Z.Anderton, Clare L.Copley, Royston C. B.Price, Louise S.Price, Sarah L.

Crystal Growth & Design (2013) 13, 6 2396

a=7.8537(6)Å   b=7.9722(5)Å   c=16.0328(18)Å

α=81.018(9)°   β=77.284(8)°   γ=66.562(5)°

6-[(5-Chloro-2-{[(4-chloro-2-fluorophenyl)methyl]oxy}phenyl)methyl]- 2-pyridinecarboxylic acid, N-methyl-2-pyrrolidone solvate (1:1)

C20H14Cl2FNO3,C5H9NO

Ismail, Salima Z.Anderton, Clare L.Copley, Royston C. B.Price, Louise S.Price, Sarah L.

Crystal Growth & Design (2013) 13, 6 2396

a=7.6611(2)Å   b=10.3298(3)Å   c=15.5587(4)Å

α=82.629(2)°   β=86.174(2)°   γ=71.791(2)°

6-[(5-Chloro-2-{[(4-chloro-2-fluorophenyl)methyl]oxy}phenyl)methyl]- 2-pyridinecarboxylic acid, DMSO solvate (1:2)

C20H14Cl2FNO3,2(C2H6OS)

Ismail, Salima Z.Anderton, Clare L.Copley, Royston C. B.Price, Louise S.Price, Sarah L.

Crystal Growth & Design (2013) 13, 6 2396

a=8.2693(2)Å   b=13.0633(4)Å   c=14.2559(4)Å

α=116.333(3)°   β=91.503(2)°   γ=105.955(3)°

1-(9H-Carbazol-4-yloxy)-3-[(2-{[2-(methyloxy)phenyl]oxy}ethyl)amino]- 2-propanol, phosphoric acid salt, hemihydrate [ratio 1:1:0.5(H2O)]

C24H27N2O4,H2O4P,0.5H2O

Vogt, Frederick G.Copley, Royston C. B.Mueller, Ronald L.Spoors, Grant P.Cacchio, Thomas N.Carlton, Robert A.Katrincic, Lee M.Kennady, James M.Parsons, SimonChetina, Olga V.

Crystal Growth & Design (2010) 10, 6 2713

a=26.6624(7)Å   b=12.2211(3)Å   c=16.3184(4)Å

α=90.00°   β=107.6220(15)°   γ=90.00°

(2R)-1-(9H-Carbazol-4-yloxy)-3-[(2-{[2-(methyloxy)phenyl]oxy}ethyl)amino]- 2-propanol, phosphoric acid salt, hemihydrate [ratio 1:1:0.5(H2O)]

C24H27N2O4,H2O4P,0.5H2O

Vogt, Frederick G.Copley, Royston C. B.Mueller, Ronald L.Spoors, Grant P.Cacchio, Thomas N.Carlton, Robert A.Katrincic, Lee M.Kennady, James M.Parsons, SimonChetina, Olga V.

Crystal Growth & Design (2010) 10, 6 2713

a=26.7679(6)Å   b=12.2428(3)Å   c=16.2786(4)Å

α=90.00°   β=108.1488(12)°   γ=90.00°

1-Methyl-7-(methyloxy)-5-[4-(trifluoromethyl)phenyl] [1,2,4]triazolo[4,3-a]quinolin-4-amine, monohydrate

C19H15F3N4O,H2O

Kang, FeirongVogt, Frederick G.Brum, JeffreyForcino, RachelCopley, Royston C. B.Williams, GlennCarlton, Robert

Crystal Growth & Design (2012) 12, 1 60

a=8.473(6)Å   b=12.542(7)Å   c=17.476(9)Å

α=102.09(4)°   β=102.70(5)°   γ=94.86(8)°

5-Ethynyl-2,4(1H,3H)-pyrimidinedione - eniluracil

C6H4N2O2

Copley, Royston C. B.Barnett, Sarah A.Karamertzanis, Panagiotis G.Harris, Kenneth D. M.Kariuki, Benson M.Xu, MingcanNickels, E. AnneLancaster, Robert W.Price, Sarah L.

Crystal Growth & Design (2008) 8, 9 3474

a=9.0169(3)Å   b=6.8086(2)Å   c=9.3777(3)Å

α=90.00°   β=101.2085(17)°   γ=90.00°

Ethyl 3-{3-[((2R)-3-{[2-(2,3-dihydro-1H-inden-2-yl)-1,1-dimethylethyl]amino}- 2-hydroxypropyl)oxy]-4,5-difluorophenyl}propanoate, hydrochloride salt

C27H36F2NO4,Cl

Vogt, Frederick G.Williams, Glenn R.Johnson, Matthew N.Copley, Royston C. B.

Crystal Growth & Design (2013) 13, 12 5353

a=7.9028(13)Å   b=13.740(3)Å   c=13.9223(16)Å

α=61.675(14)°   β=86.564(13)°   γ=84.041(17)°